Get access

Adenosine A2A receptor antagonist istradefylline for levodopa-induced complications in Parkinson's disease

  • Protocol
  • Intervention

Authors

  • Yousheng Xiao,

    1. The First Affiliated Hospital, Guangxi Medical University, Department of Neurology, Nanning, Guangxi, China
    Search for more papers by this author
  • Lu Gan,

    1. The First Affiliated Hospital, Guangxi Medical University, Department of Neurology, Nanning, Guangxi, China
    Search for more papers by this author
  • Jin Wang

    Corresponding author
    1. The First Affiliated Hospital, Guangxi Medical University, Department of Neurology, Nanning, Guangxi, China
    • Jin Wang, Department of Neurology, The First Affiliated Hospital, Guangxi Medical University, No. 22, Shuang Yong Lu, Nanning, Guangxi, 530021, China. wangjin72@126.com.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of adjuvant istradefylline therapy versus placebo in PD patients with levodopa-induced complications.

Get access to the full text of this article